Revolution Healthcare Acquisition Corp.
Status: Liquidated
U=S+W/5
W=S@11.5
| IPO Proceeds, $M | $550.00M |
|---|---|
| IPO Date | Mar 18, 2021 |
| CEO | Jay Markowitz, M.D. |
| Left Lead | Morgan Stanley |
| IPO Cash in Trust | 100.0% |
| SPAC Tenor | 24 months |
| IPO Sector |
Healthcare
Technology, health care and life sciences, including patient-centric, data-driven, cloud-based platforms |
| IPO Geography | Global |
| Target Company | N/A |
| Deal Announced | N/A |
| Deal Size, $M | TBD |
| Deal Sector | TBD |
| Deal Geography | TBD |
| SEC Filings | www.sec.gov |
| Approval Vote | TBD |
| Amendment Vote | Dec 2, 2022 |
| Closing Date | Dec 2, 2022 |
REVH
REVHU
REVHW
| Price | |
|---|---|
| Volume, 3-month avg. | N/A |
Sign up for Free Trial
No credit card required
Sign in for more on Revolution Healthcare Acquisition Corp.:
- Structure and cap table
- 8 directors & officers
- 12 filings and events
- 2 underwriters
Structure
Sign in to view structure, cap table, and calendar of events.
Team
| Name | Age | Title |
|---|---|---|
| Jay Markowitz, M.D. | 58 | Chief Executive Officer |
| Mark McDonnell | 52 | Chief Financial Officer |
| Jason Doren | 51 | Chief Administrative Officer |
| Paul Fielding | Chief Operating Officer | |
| Jeff Leiden, M.D., Ph.D | 65 | Chairman |
| Kris Engskov | 49 | Director |
| Catherine Friedman | 60 | Director |
| Jennifer Schneider, M.D. | 45 | Director |
Sign in to view team biographies and more sponsor and affiliate data.
Advisors
Underwriters
| Morgan Stanley | BR | 48,500,000 | units |
| Loop Capital Markets | 1,500,000 | ||
| 50,000,000 | units | ||
| Up-Front UW fee | 2.00 | % | |
| Deferred UW fee |
3.50 | % |
Sign in to view more advisor data.